Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Retrospective Analysis of the Impact of Adverse Event-Triggered Idelalisib Interruption and Dose Reduction on Clinical Outcomes in Patients With Relapsed/Refractory B-Cell Malignancies.
Ma S, Chan RJ, Gu L, Xing G, Rajakumaraswamy N, Ruzicka BB, Wagner-Johnston ND. Ma S, et al. Among authors: chan rj. Clin Lymphoma Myeloma Leuk. 2021 May;21(5):e432-e448. doi: 10.1016/j.clml.2020.12.016. Epub 2020 Dec 24. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33516721 Free article.
Idelalisib immune-related toxicity is associated with improved treatment response.
Wagner-Johnston ND, Sharman J, Furman RR, Salles G, Brown JR, Robak T, Gu L, Xing G, Chan RJ, Rajakumaraswamy N, Gopal AK. Wagner-Johnston ND, et al. Among authors: chan rj. Leuk Lymphoma. 2021 Dec;62(12):2915-2920. doi: 10.1080/10428194.2021.1948038. Epub 2021 Jul 28. Leuk Lymphoma. 2021. PMID: 34319205 Free PMC article.
Azacitidine Monotherapy in Patients With Treatment-Naïve Higher-risk Myelodysplastic Syndrome: A Systematic Literature Review and Meta-analysis.
Hasegawa K, Wei AH, Garcia-Manero G, Daver NG, Rajakumaraswamy N, Iqbal S, Chan RJ, Hu H, Tse P, Yan J, Zoratti MJ, Xie F, Sallman DA. Hasegawa K, et al. Among authors: chan rj. Clin Lymphoma Myeloma Leuk. 2023 Feb;23(2):127-137. doi: 10.1016/j.clml.2022.11.002. Epub 2022 Nov 6. Clin Lymphoma Myeloma Leuk. 2023. PMID: 36428152 Free article.
Text message intervention delivered from Australian general practices to improve breast cancer survivors' physical activity and cardiovascular risk factors: protocol for the EMPOWER-SMS-GP effectiveness implementation randomised controlled trial.
Singleton AC, Partridge SR, Hyun KK, Mitchell C, Raeside R, Hafiz N, Nickel B, Mizrahi D, Todd AR, McIntosh J, Chan RJ, Stuart KE, Ee C, Elder E, Redfern J. Singleton AC, et al. Among authors: chan rj. BMJ Open. 2024 Dec 11;14(12):e090984. doi: 10.1136/bmjopen-2024-090984. BMJ Open. 2024. PMID: 39663171 Free PMC article. Clinical Trial.
Application of Artificial Intelligence in Symptom Monitoring in Adult Cancer Survivorship: A Systematic Review.
Tabataba Vakili S, Haywood D, Kirk D, Abdou AM, Gopalakrishnan R, Sadeghi S, Guedes H, Tan CJ, Thamm C, Bernard R, Wong HCY, Kuhn EP, Kwan JYY, Lee SF, Hart NH, Paterson C, Chopra DA, Drury A, Zhang E, Raeisi Dehkordi S, Ashbury FD, Kotronoulas G, Chow E, Jefford M, Chan RJ, Fazelzad R, Raman S, Alkhaifi M; Multinational Association of Supportive Care in Cancer (MASCC) Survivorship Study Group. Tabataba Vakili S, et al. Among authors: chan rj. JCO Clin Cancer Inform. 2024 Dec;8:e2400119. doi: 10.1200/CCI.24.00119. Epub 2024 Dec 2. JCO Clin Cancer Inform. 2024. PMID: 39621952 Review.
311 results